Your browser doesn't support javascript.
loading
Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy.
Rao, Benjamin N; Quinn, Nicola; Januszewski, Andrzej S; Peto, Tunde; Brazionis, Laima; Aryal, Nanda; O'Connell, Rachel L; Li, Liping; Summanen, Paula; Scott, Russell; O'Day, Justin; Keech, Anthony C; Jenkins, Alicia J.
Afiliação
  • Rao BN; NHMRC Clinical Trials Centre, The University of Sydney, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia.
  • Quinn N; NHMRC Clinical Trials Centre, The University of Sydney, Australia; Centre for Public Health, Queens University, Belfast, Northern Ireland, United Kingdom.
  • Januszewski AS; NHMRC Clinical Trials Centre, The University of Sydney, Australia.
  • Peto T; Centre for Public Health, Queens University, Belfast, Northern Ireland, United Kingdom.
  • Brazionis L; Department of Medicine, St. Vincent's Hospital Campus, The University of Melbourne, Australia.
  • Aryal N; NHMRC Clinical Trials Centre, The University of Sydney, Australia.
  • O'Connell RL; NHMRC Clinical Trials Centre, The University of Sydney, Australia.
  • Li L; NHMRC Clinical Trials Centre, The University of Sydney, Australia.
  • Summanen P; Department of Ophthalmology, Helsinki University Hospital, University of Helsinki, Finland.
  • Scott R; Lipid and Diabetes Research Group, Christchurch Hospital, Christchurch, New Zealand.
  • O'Day J; Department of Ophthalmology, Royal Victorian Eye and Ear Hospital, The University of Melbourne, Australia.
  • Keech AC; NHMRC Clinical Trials Centre, The University of Sydney, Australia.
  • Jenkins AJ; NHMRC Clinical Trials Centre, The University of Sydney, Australia; Centre for Public Health, Queens University, Belfast, Northern Ireland, United Kingdom; Department of Medicine, St. Vincent's Hospital Campus, The University of Melbourne, Australia. Electronic address: Alicia.Jenkins@sydney.edu.au.
Diabetes Res Clin Pract ; 186: 109835, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35314259
ABSTRACT

AIMS:

To evaluate the risk algorithm by Aspelund et al. for predicting sight-threatening diabetic retinopathy (STDR) in Type 2 diabetes (T2D), and to develop a new STDR prediction model.

METHODS:

The Aspelund et al. algorithm was used to calculate STDR risk from baseline variables in 1012 participants in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) ophthalmological substudy, compared to on-trial STDR status, and receiver operating characteristic analysis performed. Using multivariable logistic regression, traditional risk factors and fenofibrate allocation as STDR predictors were evaluated, with bootstrap-based optimism-adjusted estimates of predictive performance calculated.

RESULTS:

STDR developed in 28 participants. The Aspelund et al. algorithm predicted STDR at 2- and 5-years with area under the curve (AUC) 0.86 (95% CI 0.77-0.94) and 0.86 (0.81-0.92), respectively. In the second model STDR risk factors were any DR at baseline (OR 24.0 [95% CI 5.53-104]), HbA1c (OR 1.95 [1.43-2.64]) and male sex (OR 4.34 [1.32-14.3]), while fenofibrate (OR 0.13 [0.05-0.38]) was protective. This model had excellent discriminatory ability (AUC = 0.89).

CONCLUSIONS:

The algorithm by Aspelund et al. predicts STDR well in the FIELD ophthalmology substudy. Logistic regression analysis found DR at baseline, male sex, and HbA1c were predictive of STDR and, fenofibrate was protective.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article